His Pacing Feasibility and Cardiac Electrical Activation
Primary Purpose
Pacing-Induced Cardiomyopathy, AV Block, Heart Failure
Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
His Pacing
Sponsored by
About this trial
This is an interventional treatment trial for Pacing-Induced Cardiomyopathy
Eligibility Criteria
Inclusion Criteria:
- Permanent pacemaker indication with expected high demand of right ventricular pacing (>40%) and left ventricular ejection fraction >40%.
Exclusion Criteria:
- No class I indication for CRT pacemaker (HRS 2018 Pacing Guidelines)
- Hemodynamically unstable patients
- Severely reduced kidney function
- Former serious adverse reactions to contrast media
- Pregnant or lactating
- Severe psychiatric disorder which can compromise compliance with protocol
Sites / Locations
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
His Pacing
Arm Description
Implant of a supplementary His pacing lead in addition to a traditional RV pacing lead.
Outcomes
Primary Outcome Measures
Rate of chronic His pacing success
Chronic His capture with clinically acceptable pacing threshold (<=3.5V)
Secondary Outcome Measures
Rate of perioperative His pacing success
Perioperative his capture with clinically acceptable pacing threshold (<=3.5V)
QRS duration (ms)
Comparing His pacing and RV pacing
Changes in left ventricular echocardiographic two-dimensional strain dyssynchrony parameters
Comparing left ventricular mechanical dyssynchrony during His pacing and RV pacing using echocardiographic two-dimensional longitudinal strain
Changes in regional right and left ventricular electrical activation delay
Comparing electrical activation pattern during His pacing and RV pacing using non-invasive electroanatomical mapping. This is achieved using software that merges data from a 12-lead electrocardiogram (ECG), chest wall three-dimensional picture of ECG lead positions, and a cardiac computed tomography scan.
Full Information
NCT ID
NCT04739553
First Posted
January 19, 2021
Last Updated
February 1, 2021
Sponsor
Aalborg University Hospital
1. Study Identification
Unique Protocol Identification Number
NCT04739553
Brief Title
His Pacing Feasibility and Cardiac Electrical Activation
Official Title
His Pacing in Patients Without Need for Cardiac Resynchronization - Clinical Feasibility and Cardiac Electrical Activation
Study Type
Interventional
2. Study Status
Record Verification Date
February 2021
Overall Recruitment Status
Not yet recruiting
Study Start Date
February 15, 2021 (Anticipated)
Primary Completion Date
January 2024 (Anticipated)
Study Completion Date
January 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Aalborg University Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
No
5. Study Description
Brief Summary
This study will examine the clinical feasibility of His pacing in patients with expected high demand for ventricular pacing and no established indication for cardiac resynchronization therapy. Secondarily, examine differences in electrical and mechanical cardiac activation between traditional pacing and His pacing.
Detailed Description
After being informed about the study and potential risks, all eligible patients giving written consent will be included. The study is a clinical single-center interventional study. The patients (n = 25) need to have an expected high demand for ventricular pacing and no established class I indication for cardiac resynchronization therapy. They will receive a pacemaker implant with a traditional right ventricular pacing lead and an additional His pacing lead in a basal high septal position at the level of the proximal electrical conduction system (His). An atrial lead is implanted if dual chamber pacing is needed. All leads are connected to a biventricular pacemaker with the His lead in the LV port. Postoperatively, the baseline examinations will include: transthoracic echocardiography, 12-lead ECG with a 3D photography of the chest wall to document ECG electrode location, and a contrast-enhanced cardiac CT scan. The echocardiography and ECG will be performed during traditional right ventricular pacing only and His pacing only. His pacing will be used as the permanent programming of choice if feasible during follow up. The CT scan is used for documenting the final positions of the pacing leads and to create a patient-specific 3D model of the cardiac electrical activation using a software which enables merging of a CT scan and ECG and a CT chest photography. During follow up (1-3 and 12 months), transthoracic echocardiography, 12-lead ECG and 3D chest photography are repeated for assessment of mechanical and electrical function during pacing. The performance of all implanted pacing lead will be evaluated at each follow up visit.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pacing-Induced Cardiomyopathy, AV Block, Heart Failure
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
25 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
His Pacing
Arm Type
Experimental
Arm Description
Implant of a supplementary His pacing lead in addition to a traditional RV pacing lead.
Intervention Type
Device
Intervention Name(s)
His Pacing
Intervention Description
The patients will receive a pacemaker implant with a traditional right ventricular pacing lead and an additional His pacing lead in a basal high septal position at the level of the proximal electrical conduction system (His). An atrial lead is implanted if dual chamber pacing is needed. All leads are connected to a biventricular pacemaker with the His lead in the LV port.
Primary Outcome Measure Information:
Title
Rate of chronic His pacing success
Description
Chronic His capture with clinically acceptable pacing threshold (<=3.5V)
Time Frame
Evaluated at 1 year follow up
Secondary Outcome Measure Information:
Title
Rate of perioperative His pacing success
Description
Perioperative his capture with clinically acceptable pacing threshold (<=3.5V)
Time Frame
The implant procedure duration i.e. incision to skin closure
Title
QRS duration (ms)
Description
Comparing His pacing and RV pacing
Time Frame
Implantation to 1 year follow up
Title
Changes in left ventricular echocardiographic two-dimensional strain dyssynchrony parameters
Description
Comparing left ventricular mechanical dyssynchrony during His pacing and RV pacing using echocardiographic two-dimensional longitudinal strain
Time Frame
Implant to 1 year follow up
Title
Changes in regional right and left ventricular electrical activation delay
Description
Comparing electrical activation pattern during His pacing and RV pacing using non-invasive electroanatomical mapping. This is achieved using software that merges data from a 12-lead electrocardiogram (ECG), chest wall three-dimensional picture of ECG lead positions, and a cardiac computed tomography scan.
Time Frame
Implant to 1 year follow up
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Permanent pacemaker indication with expected high demand of right ventricular pacing (>40%) and left ventricular ejection fraction >40%.
Exclusion Criteria:
No class I indication for CRT pacemaker (HRS 2018 Pacing Guidelines)
Hemodynamically unstable patients
Severely reduced kidney function
Former serious adverse reactions to contrast media
Pregnant or lactating
Severe psychiatric disorder which can compromise compliance with protocol
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Anna M Thøgersen, MD DMSc
Phone
+4597664427
Email
anmat@rn.dk
First Name & Middle Initial & Last Name or Official Title & Degree
Jacob M Larsen, MD PhD
Phone
+4597664456
Email
jaml@rn.dk
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sam Riahi, MD PhD
Organizational Affiliation
Aalborg University Hospital
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Peter Søgaard, MD DMSc
Organizational Affiliation
Aalborg University Hospital
Official's Role
Study Director
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
His Pacing Feasibility and Cardiac Electrical Activation
We'll reach out to this number within 24 hrs